UBC took over a Phase III prostate cancer study with a first site initiation visit planned three months later. Within this time, UBC’s Evidence Development team needed to design and begin standing up this trial without sacrificing quality post-launch which would result in slowdowns.
Utilizing our patients first mentality and a modernized approach to study design and execution, UBC was able to overcome significant risks to the study and come out with an inclusive and efficient study that is now four months ahead of schedule.
Get the full details on this success story by downloading the case study by completing the form to the right. Cover the background information, the methods UBC utilized to achieve an effective study launch so quickly, and where the program currently stands.
Subscribe Now
Subscribe Now
Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.
Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.
Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.
President & Chief Executive Officer
Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.
With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.